Entering text into the input field will update the search result below

Horizon Pharma +2.4% ahead of conference presentation

  • Horizon (NASDAQ:HZNP) presents at the JPMorgan Healthcare conference at 10:30 ET.
  • The presentation will include a financial update, and the company estimates year-end cash on hand of $500M and debt of $1.945B.
  • Full-year 2016 sales from Pennsaid, Duexis, and Vimovo are expected at roughly $600M.
  • Shares +2.4%
  • #JPM17

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
HZNP--
Horizon Therapeutics Public Limited Company
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.